OMX30 1 567 -0,9%  OMXH25 3 933 -0,9%  OMXC20 987 -1,3%  Dow 21 513 -0,3%  Nas 5 941 0,3%  EUR 9,5617 0,0%  USD 8,2177 0,0%  Olja 48,7 -0,1%  Guld 1 253 -0,7% 

Baxter International Aktie

62,75USD 0,07USD 0,11%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Baxter International Chart - 1 År - BTT

Fundamentala nyckeltal för Baxter International

2016 2017e 2018e 2019e 2020e
Utdelning 0,50 0,57 0,64 0,77 0,80
Direktavkastning (i %) 1,15 1,20 1,34 1,62 1,68
PE-tal 22,22 20,97 18,49 16,16 14,65
Resultat/aktie 1,96 2,27 2,58 2,95 3,26

Nyheter om Baxter International Inc.

ytterligare nyheter

Analyser om Baxter International Inc.

ytterligare analyser

Baxter International Peer Group

Baxter International 62,75
0,1%
Boston Scientific 27,64
0,1%
Cardinal Health 77,06
1,0%
Covidien 0,00
0,0%
Fresenius Medical Care 81,26
0,2%
Fresenius 73,46
0,0%
Hospira 0,00
0,0%
Medtronic 85,12
0,0%
STRATEC Biomedical 55,13
-4,6%
pagehit

Lägg till instrument

Vad tycker du?

Profil Baxter International Inc.till bolagsprofilen

Baxter International, Inc. provides a broad portfolio of essential renal and hospital products, including acute and chronic dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; premixed and oncolytic injectables; biosurgery products and anesthetics; drug reconstitution systems; and pharmacy automation, software and services. The company products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctor's offices and by patients at home under physician supervision. It operates through the following segments: Hospital Products and Renal. The Hospital Products segment intravenous IV solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation. The Renal segment provides products and services to treat end-stage renal disease, or irreversible kidney failure and acute kidney injuries. This segment offers a comprehensive portfolio to meet the needs of patients across the treatment continuum, including technologies and therapies for peritoneal dialysis, in-center hemodialysis, home HD, continuous renal replacement therapy and additional dialysis services. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Realtidskurs Baxter International Inc.

Bid 62,73 USD Ask 62,74 USD
Kurstid 22:00 Börsen BTT

Aktiekurs Baxter International Inc. i USDPUSH CHART

Kurs 62,75 USD 0,07 0,11 %
Kurstid 22:00:00
Datum 24.07.2017
Öppning 62,81
Gårdagen 62,68
Dagshögsta 62,88
Dagslägsta 62,50
52 v. högsta 63,10
52 v. lägsta 43,14
52 v. perf.
Volym (Antal) 118 366
Börsvärde (SEK) 277,47 Mrd
Börsen
Kurs för 62,75 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 515,66 SEK.

Till aktien Baxter International

Ticker
ISIN US0718131099
Index S&P 100, NYSE US 100, BX Swiss - USA, S&P 500

Baxter International Nyckeltal

Börsvärde i SEK 277,47 Mrd
Free float % 99,85
Antal aktier mio. 541,96
Cashflow/aktie i lokal valuta 2,28
Bokvärde/aktie i lokal valuta 17,02
60 dagar vola 22,34
PBV 2,56

Baxter International Historiska kurser

2017-07-24 62,75 118 366
2017-07-21 62,68 146 096
2017-07-20 63,07 192 595
2017-07-19 62,42 132 864
2017-07-18 62,17 151 601